These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Oral delivery of fluticasone powder improves esophageal eosinophilic inflammation and symptoms in adults with eosinophilic esophagitis. Kia L, Nelson M, Zalewski A, Gregory D, Gonsalves N, Straumann A, Hirano I. Dis Esophagus; 2018 Dec 01; 31(12):. PubMed ID: 30380044 [Abstract] [Full Text] [Related]
14. Montelukast was inefficient in maintaining steroid-induced remission in adult eosinophilic esophagitis. Lucendo AJ, De Rezende LC, Jiménez-Contreras S, Yagüe-Compadre JL, González-Cervera J, Mota-Huertas T, Guagnozzi D, Angueira T, González-Castillo S, Arias A. Dig Dis Sci; 2011 Dec 17; 56(12):3551-8. PubMed ID: 21674173 [Abstract] [Full Text] [Related]
15. Serum eosinophil cationic protein is superior to mast cell tryptase as marker for response to topical corticosteroid therapy in eosinophilic esophagitis. Schlag C, Pfefferkorn S, Brockow K, Haller B, Slotta-Huspenia J, Schulz S, von Werder A, Ring J, Schmid RM, Bajbouj M. J Clin Gastroenterol; 2014 Aug 17; 48(7):600-6. PubMed ID: 24177377 [Abstract] [Full Text] [Related]
16. 3-yr-follow-up of topical corticosteroid treatment for eosinophilic esophagitis in adults. Helou EF, Simonson J, Arora AS. Am J Gastroenterol; 2008 Sep 17; 103(9):2194-9. PubMed ID: 18637093 [Abstract] [Full Text] [Related]